Medicines

Nahid Idris Salih Khalid

Nahid Idris Salih Khalid

Dr. Nahid Salih Khalid received her Bachelor of Pharmacy in 1988 and her Masters of Pharmacy in 1999 from the University of Khartoum. During 1992-2001, she worked for the National Quality Control Laboratory as a senior quality control officer, and was involved in reviewing registration dossiers. From 1995-2002, she was a GMP inspector. Between 2001-2002, she was the head of medicine registration in Sudan. There, she updated the registration requirements according to WHO guidelines. In addition she was a member of registration committee of medicines and was the coordinator for updating the national essential medicine list.

During 2003-2007, she worked as quality assurance manager for the Central Medical Supplies (CMS) where she established a system for quality assurance after which, CMS obtained International Organization for Standardization certificate in 2003. Furthermore, Dr. Nahid Saleh activated the CMS quality control laboratory, and expanded its scope of analysis. In addition she was responsible for receiving and release of medicines and consumables in CMS. She developed specifications and supplier selection criteria for tendered items.

Currently Dr. Nahid Salih Khalid is working with the WHO in Khartoum/Sudan since 2007 as national professional officer responsible for essential medicines and pharmaceutical policies as well as health technology management programme. Many relevant activities were planned and implemented during this period including pharmaceutical sector assessment, assessment of the Revolving Drug Fund (RDF) Project in Sudan, pharmaceutical supply mapping and human resources mapping using WHO tools, Medicine Regulatory authority assessment, initiating quality control prequalification, and implementing GGM assessment. Other work included Sudan Pharmacy workforce planning and development (2009) – country case studies, quality project to update pharmaceutical marketing authorization and pharmaceutical GMP inspection systems. She strongly supported establishment of a pharmaceutical autonomous regulatory authority. She was also the coordinator for pharmaceutical country profile that published was in 2010.

Share

Presenters video at event

Presentations:

Key documents of historical value: